The Discounted Cash Flow (DCF) valuation of Evrofarma SA (EVROF.AT) is 2.34 EUR. With the latest stock price at 2.73 EUR, the upside of Evrofarma SA based on DCF is -14.2%.
Based on the latest price of 2.73 EUR and our DCF valuation, Evrofarma SA (EVROF.AT) is a sell. selling EVROF.AT stocks now will result in a potential gain of 14.2%.
| Range | Selected | |
| WACC / Discount Rate | 6.2% - 8.6% | 7.4% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 1.45 - 4.47 | 2.34 |
| Upside | -46.8% - 63.6% | -14.2% |